FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068036167> ?p ?o ?g. }

• W2068036167 endingPage "144" @default.
• W2068036167 startingPage "139" @default.
• W2068036167 abstract "Natural Killer (NK) cell lymphomas, which include the nasal and the “nasal type” varieties, are defined as angiocentric lymphomas in the revised European American Lymphoma (R.E.A.L.) classification. This group of diseases is rare in the United States and Europe but is more common in Asia and Central America. It is associated with the Epstein-Barr virus (EBV) and its response to treatment and prognosis are usually very poor. The aim of this study was to describe our experience with 13 patients with angiocentric lymphomas seen at The University of Texas M. D. Anderson Cancer Center (UTMDACC) over the last 14 years. Thirteen patients with a diagnosis of nasal NK cell lymphoma were treated at UTMDACC from 1987 to 1999. Eleven patients were treated initially with doxorubicin based chemotherapy with or without radiotherapy. One patient received interferon (IFN)-oc and vitamin A and another methotrexate, vincristine, L-Asparaginase, and radiotherapy. The median age was 44 years (range 15-76); there were four women and nine men. All patients presented with local disease involving the sinonasal region. Typical immunophenotypes expressing CD2+, CD3-and CD56+ surface markers as well as non rearrangement of T-receptors were present in all patients. Eight patients (62%) responded to therapy; six (46%) with complete response (CR) and two (16%) with partial response (PR). Five patients (38%) were alive, four with no evidence of disease (NED) at 1, 2, 3, and 9 years after treatment, and one patient was alive with disease (AWD) at the time of publication. One patient died while in CR from complications from allogeneic bone marrow transplant. Six patients had disease progression to extranodal sites including: testis (2), central nervous system (2), lung (1), bone marrow (2), liver (2), peripheral blood (2), and skin (2). In conclusion, the response to doxorubicin-containing regimens is inferior to that of patients with other non-Hodgkin's lymphomas and similar prognostic factors. Because the disease is associated with EBV virus in 90% - 100% of the cases and the prognosis is poor, innovative therapies should be tried including immunotherapy that targets the expression of EBV by the tumor with or without myeloablative procedures." @default.
• W2068036167 created "2016-06-24" @default.
• W2068036167 creator A5000750846 @default.
• W2068036167 creator A5035410664 @default.
• W2068036167 creator A5040275365 @default.
• W2068036167 creator A5044201739 @default.
• W2068036167 creator A5048849075 @default.
• W2068036167 creator A5078188105 @default.
• W2068036167 creator A5089736242 @default.
• W2068036167 date "2000-01-01" @default.
• W2068036167 modified "2023-10-18" @default.
• W2068036167 title "Nasal-Type T/NK Lymphomas: A Clinicopathologic Study of 13 Cases" @default.
• W2068036167 cites W148449817 @default.
• W2068036167 cites W2024868664 @default.
• W2068036167 cites W2026540048 @default.
• W2068036167 cites W2057363850 @default.
• W2068036167 cites W2057742295 @default.
• W2068036167 cites W2107202569 @default.
• W2068036167 cites W2266123463 @default.
• W2068036167 cites W2297036705 @default.
• W2068036167 cites W2409952111 @default.
• W2068036167 cites W3112793215 @default.
• W2068036167 cites W4246270713 @default.
• W2068036167 cites W4254200411 @default.
• W2068036167 cites W4293241248 @default.
• W2068036167 doi "https://doi.org/10.3109/10428190009053547" @default.
• W2068036167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10975392" @default.
• W2068036167 hasPublicationYear "2000" @default.
• W2068036167 type Work @default.
• W2068036167 sameAs 2068036167 @default.
• W2068036167 citedByCount "55" @default.
• W2068036167 countsByYear W20680361672012 @default.
• W2068036167 countsByYear W20680361672013 @default.
• W2068036167 countsByYear W20680361672014 @default.
• W2068036167 countsByYear W20680361672015 @default.
• W2068036167 countsByYear W20680361672016 @default.
• W2068036167 countsByYear W20680361672017 @default.
• W2068036167 countsByYear W20680361672019 @default.
• W2068036167 crossrefType "journal-article" @default.
• W2068036167 hasAuthorship W2068036167A5000750846 @default.
• W2068036167 hasAuthorship W2068036167A5035410664 @default.
• W2068036167 hasAuthorship W2068036167A5040275365 @default.
• W2068036167 hasAuthorship W2068036167A5044201739 @default.
• W2068036167 hasAuthorship W2068036167A5048849075 @default.
• W2068036167 hasAuthorship W2068036167A5078188105 @default.
• W2068036167 hasAuthorship W2068036167A5089736242 @default.
• W2068036167 hasConcept C126322002 @default.
• W2068036167 hasConcept C141071460 @default.
• W2068036167 hasConcept C2776694085 @default.
• W2068036167 hasConcept C2776755627 @default.
• W2068036167 hasConcept C2778311950 @default.
• W2068036167 hasConcept C2779338263 @default.
• W2068036167 hasConcept C2779429289 @default.
• W2068036167 hasConcept C509974204 @default.
• W2068036167 hasConcept C71924100 @default.
• W2068036167 hasConcept C90924648 @default.
• W2068036167 hasConceptScore W2068036167C126322002 @default.
• W2068036167 hasConceptScore W2068036167C141071460 @default.
• W2068036167 hasConceptScore W2068036167C2776694085 @default.
• W2068036167 hasConceptScore W2068036167C2776755627 @default.
• W2068036167 hasConceptScore W2068036167C2778311950 @default.
• W2068036167 hasConceptScore W2068036167C2779338263 @default.
• W2068036167 hasConceptScore W2068036167C2779429289 @default.
• W2068036167 hasConceptScore W2068036167C509974204 @default.
• W2068036167 hasConceptScore W2068036167C71924100 @default.
• W2068036167 hasConceptScore W2068036167C90924648 @default.
• W2068036167 hasIssue "1-2" @default.
• W2068036167 hasLocation W20680361671 @default.
• W2068036167 hasLocation W20680361672 @default.
• W2068036167 hasOpenAccess W2068036167 @default.
• W2068036167 hasPrimaryLocation W20680361671 @default.
• W2068036167 hasRelatedWork W1978070076 @default.
• W2068036167 hasRelatedWork W2036802760 @default.
• W2068036167 hasRelatedWork W2083438316 @default.
• W2068036167 hasRelatedWork W2111618869 @default.
• W2068036167 hasRelatedWork W2145349532 @default.
• W2068036167 hasRelatedWork W2330662417 @default.
• W2068036167 hasRelatedWork W2342164759 @default.
• W2068036167 hasRelatedWork W2411620672 @default.
• W2068036167 hasRelatedWork W2418155614 @default.
• W2068036167 hasRelatedWork W2559245262 @default.
• W2068036167 hasVolume "39" @default.
• W2068036167 isParatext "false" @default.
• W2068036167 isRetracted "false" @default.
• W2068036167 magId "2068036167" @default.
• W2068036167 workType "article" @default.